博雅生物 内部交易概览
暂无关于该公司的高管股东内部交易数据
暂无关于该公司18月以内的内部交易数据
博雅生物 内部交易
博雅生物 最新内部交易
梁小明 | Directors, executives | 2021-06-16 | 买入 | 10,000 | 629,200 |
¥33.82
|
-7.51%
|
梁小明 | Directors, executives | 2021-05-11 | 买入 | 20,000 | 619,200 |
¥33.33
|
-6.15%
|
梁小明 | Directors, executives | 2021-05-06 | 买入 | 10,000 | 599,200 |
¥33.88
|
-7.67%
|
梁小明 | Directors, executives | 2021-03-23 | 买入 | 30,000 | 589,200 |
¥28.66
|
+9.14%
|
张石方 | Executives | 2021-03-18 | 买入 | 35,300 | 71,300 |
¥28.25
|
+10.73%
|
李寿孙 | Executives | 2021-03-18 | 买入 | 5,500 | 56,100 |
¥29
|
+7.86%
|
涂言实 | Directors, executives | 2021-03-17 | 买入 | 47,400 | 55,700 |
¥28
|
+11.71%
|
张石方 | Executives | 2021-03-17 | 买入 | 36,000 | 36,000 |
¥28.28
|
+10.61%
|
陈兵 | Executives | 2021-03-17 | 买入 | 71,300 | 71,300 |
¥28.02
|
+11.63%
|
李寿孙 | Executives | 2021-03-17 | 买入 | 36,400 | 50,600 |
¥28.2
|
+10.92%
|